Table 1.
Patient data
| Patient number | Knee | Gender | Age (years) | Underlying diagnosis | Steroid use at time of OCA | Number of grafts | Condyle | Total graft area (cm2) | Graft technique | Bone grafting | Followup (months) | 18-point D’Aubigné and Postel score/outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 01 | Female | 19 | Sickle cell anemia | No | 1 | Medial | Shell | No | 48 | 18 | |
| 2 | 02 | Male | 17 | Leukemia | No | 1 | Lateral | 9.9 | Shell | Yes | 27 | 17 |
| 03 | Male | 17 | Leukemia | No | 1 | Lateral | 11.6 | Shell | Yes | 27 | 17 | |
| 3 | 04 | Female | 16 | Leukemia | No | 2 | Medial and lateral | 11.8 | Shell | No | 45* | Revision allograft |
| 05 | Female | 17 | Leukemia | No | 1 | Lateral | 11.0 | Shell | Yes | 34 | 12 | |
| 4 | 06 | Female | 25 | SLE | No | 2 | Medial and lateral | 9.25 | Shell | No | 34 | 14 |
| 5 | 07 | Female | 39 | Crohn’s disease | No | 1 | Lateral | 17.2 | Shell | No | 122 | 11 |
| 08 | Female | 40 | Crohn’s disease | No | 2 | Medial and lateral | 9.2 | Shell | No | 115 | 11 | |
| 6 | 09 | Male | 25 | SLE | No | 1 | Medial | 17.5 | Shell | Yes | 46 | 18 |
| 7 | 10 | Male | 29 | Leukemia | No | 2 | Lateral | 6.3 | Plug | Yes | 25 | 18 |
| 8 | 11 | Female | 25 | SLE | Yes (unknown dosage) | 1 | Lateral | 5.25 | Shell | Yes | 30 | 17 |
| 9 | 12 | Male | 35 | Ulcerative colitis | No | 1 | Medial | 9.0 | Plug | Yes | 93 | 11 |
| 13 | Male | 32 | Ulcerative colitis | No | 2 | Medial and lateral | 7.4 | Shell | Yes | 127 | 11 | |
| 10 | 14 | Female | 21 | Leukemia | No | 1 | Medial | 10.0 | Shell | No | 96 | 16 |
| 11 | 15 | Female | 36 | Closed head injury | No | 1 | Lateral | 7.8 | Shell | No | 235 | 18 |
| 12 | 16 | Female | 17 | Hodgkin’s lymphoma | No | 3 | Medial | 11.2 | Plug | Yes | 33 | 16 |
| 17 | Female | 17 | Hodgkin’s lymphoma | No | 3 | Medial | 12.0 | Plug | Yes | 33 | 16 | |
| 13 | 18 | Female | 21 | Leukemia | No | 3 | Medial and lateral | 19.0 | Plug | Yes | 64 | 16 |
| 14 | 19 | Female | 18 | Renal transplant | No | 1 | Lateral | 11.0 | Shell | Yes | 98 | 17 |
| 15 | 20 | Female | 30 | Transient allergies | No | 2 | Medial and lateral | 13.75 | Shell | Yes | 78* | TKA |
| 16 | 21 | Female | 23 | SLE | No | 2 | Lateral | 10.5 | Shell | Yes | 159 | 16 |
| 17 | 22 | Female | 18 | Leukemia | No | 1 | Lateral | 5.0 | Plug | No | 35 | 18 |
| 23 | Female | 18 | Leukemia | No | 1 | Medial | 9.7 | Shell | Yes | 35 | 18 | |
| 18 | 24 | Female | 20 | Ulcerative colitis | No | 2 | Medial | 6.3 | Plug | Yes | 44 | 18 |
| 19 | 25 | Female | 18 | SLE | No | 3 | Medial and lateral | 19.0 | Plug | Yes | 40* | Revision allograft |
| 20 | 26 | Female | 44 | Renal infection | No | 1 | Lateral | 10 | Shell | No | 26 | 17 |
| 21 | 27 | Male | 28 | Ulcerative colitis | No | 2 | Medial | 8.5 | Plug | Yes | 46 | 17 |
| 22 | 28 | Male | 16 | Myositis | Yes (40 mg/day) | 1 | Lateral | 12.6 | Shell | No | 48 | 16 |
* Time to revision/conversion; OCA = osteochondral allografting; SLE = systemic lupus erythematosus.